A semiquantitative metric for evaluating clinical actionability of incidental or secondary findings from genome-scale sequencing

[1]  K. Owen,et al.  Glucokinase MODY and Implications for Treatment Goals of Common Forms of Diabetes , 2014, Current Diabetes Reports.

[2]  Christine Weiner,et al.  Anticipate and communicate: Ethical management of incidental and secondary findings in the clinical, research, and direct-to-consumer contexts (December 2013 report of the Presidential Commission for the Study of Bioethical Issues). , 2014, American journal of epidemiology.

[3]  Rena A. Godfrey,et al.  The implications of familial incidental findings from exome sequencing: The NIH Undiagnosed Diseases Program experience , 2014, Genetics in Medicine.

[4]  Carolyn Y. Ho,et al.  Hypertrophic Cardiomyopathy Overview , 2014 .

[5]  Robert C. Green,et al.  Processes and preliminary outputs for identification of actionable genes as incidental findings in genomic sequence data in the Clinical Sequencing Exploratory Research Consortium , 2013, Genetics in Medicine.

[6]  L. Gepstein,et al.  Flecainide therapy suppresses exercise-induced ventricular arrhythmias in patients with CASQ2-associated catecholaminergic polymorphic ventricular tachycardia. , 2013, Heart rhythm.

[7]  Emily H Turner,et al.  Actionable, pathogenic incidental findings in 1,000 participants' exomes. , 2013, American journal of human genetics.

[8]  E. Clayton,et al.  Premature guidance about whole-genome sequencing. , 2013, Personalized medicine.

[9]  B. Knoppers,et al.  Recommendations for returning genomic incidental findings? We need to talk! , 2013, Genetics in Medicine.

[10]  Marc S. Williams,et al.  ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing , 2013, Genetics in Medicine.

[11]  Susan M Wolf,et al.  Patient Autonomy and Incidental Findings in Clinical Genomics , 2013, Science.

[12]  J. Elefteriades,et al.  The genetics and genomics of thoracic aortic disease. , 2013, Annals of cardiothoracic surgery.

[13]  B. Knoppers,et al.  Whole-genome sequencing in health care , 2013, European Journal of Human Genetics.

[14]  Jonathan S. Berg,et al.  Response to Lindor et al. , 2013, Genetics in Medicine.

[15]  Eric W. Klee,et al.  Preserving personal autonomy in a genomic testing era , 2013, Genetics in Medicine.

[16]  Elizabeth M Webber,et al.  Description and pilot results from a novel method for evaluating return of incidental findings from next-generation sequencing technologies , 2013, Genetics in Medicine.

[17]  James P Evans,et al.  An informatics approach to analyzing the incidentalome , 2012, Genetics in Medicine.

[18]  Larry N. Singh,et al.  Secondary variants in individuals undergoing exome sequencing: screening of 572 individuals identifies high-penetrance mutations in cancer-susceptibility genes. , 2012, American journal of human genetics.

[19]  A. Davis,et al.  Guidelines for the diagnosis and management of Catecholaminergic Polymorphic Ventricular Tachycardia. , 2012, Heart, lung & circulation.

[20]  Barry J Maron,et al.  2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Executive Summary A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines , 2011, Circulation.

[21]  B. Bacon,et al.  Diagnosis and Management of Hemochromatosis: 2011 Practice Guideline by the American Association for the Study of Liver Diseases , 2011, Hepatology.

[22]  Muin J Khoury,et al.  Deploying whole genome sequencing in clinical practice and public health: Meeting the challenge one bin at a time , 2011, Genetics in Medicine.

[23]  N. Christensen,et al.  Malignant pheochromocytomas and paragangliomas - the importance of a multidisciplinary approach. , 2011, Cancer treatment reviews.

[24]  M. Goetz,et al.  PTEN hamartoma tumor syndrome (PHTS): Clinical characteristics, onco-phenotype, and molecular analysis. , 2010 .

[25]  B. Weschke,et al.  Glucose transporter-1 deficiency syndrome: the expanding clinical and genetic spectrum of a treatable disorder. , 2010, Brain : a journal of neurology.

[26]  Bridget Wilcken,et al.  Fatty acid oxidation disorders: outcome and long-term prognosis , 2010, Journal of Inherited Metabolic Disease.

[27]  J. Witteman,et al.  Efficacy of statins in familial hypercholesterolaemia: a long term cohort study , 2008, BMJ : British Medical Journal.

[28]  P. Dennis,et al.  PTEN hamartoma tumor syndromes , 2008, European Journal of Human Genetics.

[29]  B. Poorthuis,et al.  Sanfilippo syndrome: A mini-review , 2008, Journal of Inherited Metabolic Disease.

[30]  J. Dean.  Marfan syndrome: clinical diagnosis and management , 2007, European Journal of Human Genetics.

[31]  E. Varga.  Inherited Thrombophilia: Key Points for Genetic Counseling , 2007, Journal of Genetic Counseling.

[32]  Peter Choyke,et al.  Evaluation and management of renal tumors in the Birt-Hogg-Dubé syndrome. , 2005, The Journal of urology.

[33]  T. Voit,et al.  Effects of the ketogenic diet in the glucose transporter 1 deficiency syndrome. , 2004, Prostaglandins, leukotrienes, and essential fatty acids.

[34]  W. Young,et al.  Familial malignant catecholamine-secreting paraganglioma with prolonged survival associated with mutation in the succinate dehydrogenase B gene. , 2002, The Journal of clinical endocrinology and metabolism.

[35]  P. Prandoni,et al.  Incidence of venous thromboembolism in asymptomatic family members who are carriers of factor V Leiden: a prospective cohort study. , 2002, Blood.

[36]  A. Tavill.  Diagnosis and management of hemochromatosis , 2001, Hepatology.

[37]  L. Aaltonen,et al.  Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. , 2000, Gastroenterology.

[38]  C. Eng,et al.  Mutation analysis reveals novel sequence variants in NTRK1 in sporadic human medullary thyroid carcinoma. , 1999, The Journal of clinical endocrinology and metabolism.

[39]  Pascal Borry,et al.  Whole-genome sequencing in health care. Recommendations of the European Society of Human Genetics. , 2013, European journal of human genetics : EJHG.

[40]  T. Harris.  Anticipate and Communicate: Ethical Management of Incidental and Secondary Findings in the Clinical, Research, and Direct-to-Consumer Contexts , 2013 .

[41]  Patrick L. Taylor,et al.  The Informed Cohort Oversight Board: From Values to Architecture. , 2012, Minnesota journal of law, science & technology.

[42]  H. Gharib,et al.  Familial dysalbuminemic hyperthyroxinemia: cumulative experience in 29 consecutive patients. , 1995, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[43]  C. Eng.  PTEN Hamartoma Tumor Syndrome (PHTS)-GeneReviews-NCBI Bookshelf , 2022 .